Analysts expect that ICU Medical, Incorporated (NASDAQ:ICUI) will report earnings of $2.09 per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for ICU Medical’s earnings. The lowest EPS estimate is $2.08 and the highest is $2.09. ICU Medical posted earnings of $2.66 per share in the same quarter last year, which would suggest a negative year-over-year growth rate of 21.4%. The company is expected to issue its next earnings report on Thursday, August 8th.
On average, analysts expect that ICU Medical will report full-year earnings of $9.39 per share for the current year, with EPS estimates ranging from $9.33 to $9.45. For the next fiscal year, analysts anticipate that the business will post earnings of $10.16 per share, with EPS estimates ranging from $10.08 to $10.23. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research firms that cover ICU Medical.
ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Thursday, May 9th. The medical instruments supplier reported $2.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.96 by $0.39. The company had revenue of $330.93 million for the quarter, compared to the consensus estimate of $318.97 million. ICU Medical had a return on equity of 13.70% and a net margin of 4.04%. The company’s quarterly revenue was down 11.0% on a year-over-year basis. During the same period in the previous year, the business earned $2.26 earnings per share.
In related news, CFO Scott E. Lamb sold 25,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 26th. The shares were sold at an average price of $250.00, for a total value of $6,250,000.00. Following the completion of the transaction, the chief financial officer now owns 34,984 shares in the company, valued at approximately $8,746,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert S. Swinney sold 229 shares of the business’s stock in a transaction that occurred on Friday, April 12th. The stock was sold at an average price of $231.43, for a total transaction of $52,997.47. Following the completion of the transaction, the director now owns 18,076 shares of the company’s stock, valued at approximately $4,183,328.68. The disclosure for this sale can be found here. Insiders sold 37,921 shares of company stock valued at $9,221,607 in the last quarter. 11.40% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently bought and sold shares of the stock. Zurcher Kantonalbank Zurich Cantonalbank raised its position in ICU Medical by 6.5% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,118 shares of the medical instruments supplier’s stock worth $268,000 after purchasing an additional 68 shares during the last quarter. Oregon Public Employees Retirement Fund raised its position in ICU Medical by 1.4% in the 1st quarter. Oregon Public Employees Retirement Fund now owns 6,646 shares of the medical instruments supplier’s stock worth $1,591,000 after purchasing an additional 90 shares during the last quarter. Advisory Services Network LLC raised its position in ICU Medical by 475.0% in the 4th quarter. Advisory Services Network LLC now owns 115 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 95 shares during the last quarter. California State Teachers Retirement System raised its position in ICU Medical by 0.4% in the 1st quarter. California State Teachers Retirement System now owns 24,666 shares of the medical instruments supplier’s stock worth $5,903,000 after purchasing an additional 99 shares during the last quarter. Finally, Retirement Systems of Alabama raised its position in ICU Medical by 0.5% in the 1st quarter. Retirement Systems of Alabama now owns 21,615 shares of the medical instruments supplier’s stock worth $5,173,000 after purchasing an additional 109 shares during the last quarter. Hedge funds and other institutional investors own 90.05% of the company’s stock.
NASDAQ ICUI opened at $251.91 on Friday. ICU Medical has a 1-year low of $210.94 and a 1-year high of $321.70. The firm’s 50 day moving average is $231.86. The firm has a market capitalization of $5.11 billion, a P/E ratio of 32.67 and a beta of 0.72.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Recommended Story: Recession
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.